DISEASE INDICATIONS: Multiple Sclerosis

MANUFACTURER: Roche Registration Limited

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Medsafe (NZ)

Ocrevus (ocrelizumab) is an intravenous prescription medication prescribed for the treatment of multiple sclerosis (MS), which helps prevent nerve damage and relapses by targeting B cells. Ocrevus is mostly used to modify and slow down the progression of relapsing-remitting MS and primary progressive MS.